子宫肌瘤规范化治疗中的个体化

袁江静, 王玉东

中国实用妇科与产科杂志 ›› 2026, Vol. 42 ›› Issue (1) : 51-54.

PDF(993 KB)
PDF(993 KB)
中国实用妇科与产科杂志 ›› 2026, Vol. 42 ›› Issue (1) : 51-54. DOI: 10.19538/j.fk2026010113
专题笔谈

子宫肌瘤规范化治疗中的个体化

作者信息 +

Individualization in standardized treatment of uterine fibroids

Author information +
文章历史 +

摘要

子宫肌瘤是最常见的女性生殖系统良性肿瘤,治疗策略包括药物、手术以及子宫动脉栓塞术、聚焦超声消融、射频消融等。手术方式主要为肌瘤剔除和全子宫切除,手术路径包括宫腔镜、腹腔镜、经腹等。规范治疗方式需根据瘤体大小、数量、位置、症状、患者的生育需求以及特殊亚型等因素进行个体化评估和决策。另外,一些特殊类型的子宫肌瘤的诊治也需要给予关注。

Abstract

Uterine fibroids are the most common benign tumors of the female reproductive system. Treatment strategies include pharmacological management,surgical interventions,as well as minimally invasive procedures such as uterine artery embolization,focused ultrasound ablation,and radiofrequency ablation. Surgical approaches are primarily categorized into myomectomy and hysterectomy,with procedural pathways including hysteroscopy,laparoscopy,and laparotomy. Standardized treatment decision-making requires individualized evaluation based on factors such as the size,number,and location of the fibroids,associated symptoms,the patient’s fertility desires,and specific subtypes of fibroids. Additionally,special attention should be given to the diagnosis and management of certain unique types of uterine fibroids.

关键词

子宫肌瘤 / 肌瘤剔除 / 腹腔镜 / 个体化治疗

Key words

uterine fibroids / myomectomy / laparoscopy / individualized treatment

引用本文

导出引用
袁江静, 王玉东. 子宫肌瘤规范化治疗中的个体化[J]. 中国实用妇科与产科杂志. 2026, 42(1): 51-54 https://doi.org/10.19538/j.fk2026010113
YUAN Jiang-jing, WANG Yu-dong. Individualization in standardized treatment of uterine fibroids[J]. Chinese Journal of Practical Gynecology and Obstetrics. 2026, 42(1): 51-54 https://doi.org/10.19538/j.fk2026010113
中图分类号: R711.74   

参考文献

[1]
叶明珠, 薛敏. 子宫肌瘤微无创治疗的适应证和禁忌证[J]. 中国实用妇科与产科杂志, 2024, 40(9):886-891. DOI:10.19538/j.fk2024090107.
[2]
Expert Panel on GYN and OB Imaging,Ascher SM, Wasnik AP, et al. ACR Appropriateness Criteria® Fibroids[J]. J Am Coll Radiol, 2022, 19(11S):S319-S328. DOI:10.1016/j.jacr.2022.09.019.
[3]
子宫肌瘤的诊治中国专家共识专家组. 子宫肌瘤的诊治中国专家共识[J]. 中华妇产科杂志, 2017, 52(12):793-800. DOI:10.3760/cma.j.issn.0529-567x.2017.12.001.
[4]
王绍光, 陈勇华. 子宫肌瘤和子宫腺肌病动脉栓塞治疗手术质量控制[J]. 中国实用妇科与产科杂志, 2022, 38(1):51-55. DOI:10.19538/j.fk2022010114.
[5]
Daniels J, Middleton LJ, Cheed V, et al. Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy:the FEMME RCT[J]. Health Technol Assess, 2022, 26(22):1-74. DOI:10.3310/ZDEG6110.
[6]
Mara M, Maskova J, Fucikova Z, et al. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy[J]. Cardiovasc Intervent Radiol, 2008, 31(1):73-85. DOI:10.1007/s00270-007-9195-2.
[7]
Homer H, Saridogan E. Uterine artery embolization for fibroids is associated with an increased risk of miscarriage[J]. Fertil Steril, 2010, 94(1):324-330. DOI:10.1016/j.fertnstert.2009.02.069.
[8]
Jegaden M, Bleas C, Debras E, et al. Asherman syndrome after uterine artery embolization: a cohort study about surgery management and fertility outcomes[J]. J Minim Invasive Gynecol, 2023, 30(6):494-501. DOI:10.1016/j.jmig.2023.02.012.
[9]
王智彪. 聚焦超声消融手术的过去、现在与未来[J]. 中国实用妇科与产科杂志, 2024, 40(9):872-875. DOI:10.19538/j.fk2024090103.
[10]
de Smit NS, de Lange ME, Boomsma MF, et al. Current treatment for symptomatic uterine fibroids:available evidence and therapeutic dilemmas[J]. Lancet, 2025, 406(10498):91-102. DOI:10.1016/S0140-6736(25)00728-7.
[11]
Saridogan E, Antoun L, Bouwsma EVA, et al. European Society for Gynaecological Endoscopy (ESGE) Good Practice Recommendations on surgical techniques for removal of fibroids:part 1 abdominal (laparoscopic and open) myomectomy[J]. Facts Views Vis Obgyn, 2024, 16(3):263-280. DOI:10.52054/FVVO.16.3.041.
[12]
卢邦春, 李玉宏, 黄勇, 等. 巨大子宫阔韧带肌瘤一例[J]. 中国妇产科临床杂志, 2018, 19(1):77-78. DOI:10.13390/j.issn.1672-1861.2018.01.030.
[13]
Litta P, Conte L, De Marchi F, et al. Pregnancy outcome after hysteroscopic myomectomy[J]. Gynecol Endocrinol, 2014, 30(2):149-152. DOI:10.3109/09513590.2013.863861.
[14]
Wise LA, Thomas L, Anderson S, et al. Route of myomectomy and fertility: a prospective cohort study[J]. Fertil Steril, 2022, 117(5):1083-1093. DOI:10.1016/j.fertnstert.2022.01.013.
[15]
梁静, 凌斌. 腹腔镜下子宫肌瘤剔除术质量控制[J]. 中国实用妇科与产科杂志, 2022, 38(1):32-36. DOI:10.19538/j.fk2022010109.
[16]
Expert Panel on Interventional Radiology,Makary MS, Zane K, et al. ACR Appropriateness Criteria® Management of Uterine Fibroids:2023 Update[J]. J Am Coll Radiol, 2024, 21(6S):S203-S218. DOI:10.1016/j.jacr.2024.02.022.
[17]
Gu W, Yuan J, Zhou Y, et al. Impact of ultrasound-guided high-intensity focused ultrasound for the treatment of uterine fibroids on ovarian reserve and quality of life:a single-center prospective cohort study[J]. BMC Womens Health, 2024, 24(1):470. DOI:10.1186/s12905-024-03315-5.
[18]
文怡. 子宫肌瘤和子宫腺肌病聚焦超声消融手术术后中医辨证治疗[J]. 中国实用妇科与产科杂志, 2024, 40(9):908-912. DOI:10.19538/j.fk2024090113.
[19]
Zou M, Chen L, Wu C, et al. Pregnancy outcomes in patients with uterine fibroids treated with ultrasound-guided high-intensity focused ultrasound[J]. BJOG, 2017, 124(Suppl 3):30-35. DOI:10.1111/1471-0528.14742.
[20]
Zhou Y, Chen P, Ji X, et al. Long-term efficacy of fibroid devascularization with ultrasound-guided high-intensity focused ultrasound[J]. Acad Radiol, 2024, 31(5):1931-1939. DOI:10.1016/j.acra.2023.10.045.
[21]
杨华, 冯凤芝, 范融, 等. 延胡索酸水化酶缺陷相关子宫肌瘤临床特点分析[J]. 中国实用妇科与产科杂志, 2022, 38(3):319-322. DOI:10.19538/j.fk2022030114.
[22]
Tong T, Fan Q, Wang Y, et al. Benign metastasizing uterine leiomyoma with lymphatic and pulmonary metastases: a case report and literature review[J]. BMC Womens Health, 2023, 23(1):154. DOI:10.1186/s12905-023-02237-y.
[23]
Hensley ML, Enserro D, Hatcher H, et al. Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for high-grade uterine leiomyosarcoma: a phase Ⅲ nrg oncology/gynecologic oncology group study[J]. J Clin Oncol, 2018, 36(33):JCO1800454. DOI:10.1200/JCO.18.00454.
[24]
Wang YW, Fan Q, Qian ZX, et al. Abdominopelvic leiomyoma with large ascites:A case report and review of the literature[J]. World J Clin Cases, 2021, 9(6):1424-1432. DOI:10.12998/wjcc.v9.i6.1424.

脚注

利益冲突 作者声明不存在利益冲突

基金

国家自然科学基金(82573837)
上海市东方英才计划领军项目(LJ2024085)
国家卫健委/国家中医药管理局医疗服务与保障能力提升项目(ZXYXTQJ-2025)

PDF(993 KB)

Accesses

Citation

Detail

段落导航
相关文章

/